Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial
Brooklyn, T N, Dunnill, M G S, Shetty, A, Bowden, J J, Williams, J D L, Griffiths, C E M, Forbes, A, Greenwood, R, Probert, C S
Published in Gut (01.04.2006)
Published in Gut (01.04.2006)
Get full text
Journal Article
Review article: cytomegalovirus and inflammatory bowel disease
Sager, K., Alam, S., Bond, A., Chinnappan, L., Probert, C. S.
Published in Alimentary pharmacology & therapeutics (01.04.2015)
Published in Alimentary pharmacology & therapeutics (01.04.2015)
Get full text
Journal Article
Communication of prostate cancer cells with bone cells via extracellular vesicle RNA; a potential mechanism of metastasis
Probert, C., Dottorini, T., Speakman, A., Hunt, S., Nafee, T., Fazeli, A., Wood, S., Brown, J. E., James, V.
Published in Oncogene (01.03.2019)
Published in Oncogene (01.03.2019)
Get full text
Journal Article
Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study
Marteau, P, Probert, C S, Lindgren, S, Gassul, M, Tan, T G, Dignass, A, Befrits, R, Midhagen, G, Rademaker, J, Foldager, M
Published in Gut (01.07.2005)
Published in Gut (01.07.2005)
Get full text
Journal Article
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial
Probert, C S J, Hearing, S D, Schreiber, S, Kühbacher, T, Ghosh, S, Arnott, I D R, Forbes, A
Published in Gut (01.07.2003)
Published in Gut (01.07.2003)
Get full text
Journal Article
Almonds and their impact on gastrointestinal physiology, luminal microbiology and gastrointestinal function: a randomised controlled trial
Creedon, A.C., Dimidi, E., Hung, E.S., Scott, S.M., Probert, C., Berry, S.E., Whelan, K.
Published in Proceedings of the Nutrition Society (2022)
Published in Proceedings of the Nutrition Society (2022)
Get full text
Journal Article
Randomised clinical trial: once‐ vs. twice‐daily prolonged‐release mesalazine for active ulcerative colitis
Flourié, B., Hagège, H., Tucat, G., Maetz, D., Hébuterne, X., Kuyvenhoven, J. P., Tan, T. G., Pierik, M. J., Masclee, A. A. M., Dewit, O., Probert, C. S., Aoucheta, D.
Published in Alimentary pharmacology & therapeutics (01.04.2013)
Published in Alimentary pharmacology & therapeutics (01.04.2013)
Get full text
Journal Article
A pilot study of faecal volatile organic compounds in faeces from cholera patients in Bangladesh to determine their utility in disease diagnosis
Garner, C.E., Smith, S., Bardhan, P.K., Ratcliffe, N.M., Probert, C.S.J.
Published in Transactions of the Royal Society of Tropical Medicine and Hygiene (01.11.2009)
Published in Transactions of the Royal Society of Tropical Medicine and Hygiene (01.11.2009)
Get full text
Journal Article
Pancreatic cancer biomarker from urinary volatile organic compounds
Aggarwal, P., Baker, J., Chapman, E., Greenhalf, B., Costello-Goldring, E., Probert, C.
Published in Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] (01.11.2020)
Published in Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] (01.11.2020)
Get full text
Journal Article
Towards point of care testing for C. difficile infection by volatile profiling, using the combination of a short multi-capillary gas chromatography column with metal oxide sensor detection
McGuire, N D, Ewen, R J, de Lacy Costello, B, Garner, C E, Probert, C S J, Vaughan, K, Ratcliffe, N M
Published in Measurement science & technology (12.05.2014)
Published in Measurement science & technology (12.05.2014)
Get full text
Journal Article
Basiliximab for the treatment of steroid‐resistant ulcerative colitis: further experience in moderate and severe disease
CREED, T. J., PROBERT, C. S. J., NORMAN, M. N., MOORGHEN, M., SHEPHERD, N. A., HEARING, S. D., DAYAN, C. M.
Published in Alimentary pharmacology & therapeutics (01.05.2006)
Published in Alimentary pharmacology & therapeutics (01.05.2006)
Get full text
Journal Article
Low FODMAP diet & prebiotic β-galactooligosaccharides improve irritable bowel syndrome and response to low FODMAP is predicted by urine and faecal metabolites: a randomised controlled trial
Wilson, B., Rossi, M., Kanno, T., Hough, R., Probert, C., Parkes, G., Anderson, S., Irving, P., Mason, A.J., Lomer, M.C., Whelan, K.
Published in Proceedings of the Nutrition Society (2020)
Published in Proceedings of the Nutrition Society (2020)
Get full text
Journal Article
Letter: faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease and Letter: faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Authors’ reply
Ahmed, I., Greenwood, R., Costello, B., Ratcliffe, N., Probert, C.
Published in Alimentary pharmacology & therapeutics (01.06.2016)
Published in Alimentary pharmacology & therapeutics (01.06.2016)
Get full text
Journal Article
Volatiles from oral anaerobes confounding breath biomarker discovery
Khalid, T Y, Saad, Saliha, Greenman, John, de Lacy Costello, B, Probert, C S J, Ratcliffe, N M
Published in Journal of breath research (01.03.2013)
Published in Journal of breath research (01.03.2013)
Get full text
Journal Article
Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver disease
Reid, D.T., McDonald, B., Khalid, T., Vo, T., Schenck, L.P., Surette, M.G., Beck, P.L., Reimer, R.A., Probert, C.S., Rioux, K.P., Eksteen, B.
Published in Biochimica et biophysica acta (01.07.2016)
Published in Biochimica et biophysica acta (01.07.2016)
Get full text
Journal Article
Early Use of Azathioprine in Crohn's Disease
Hawthorne, A.B, Probert, C.S.J, Sanderson, J.D
Published in Gastroenterology (New York, N.Y. 1943) (01.03.2014)
Published in Gastroenterology (New York, N.Y. 1943) (01.03.2014)
Get full text
Journal Article